Does TERAZOSIN Cause Transplant dysfunction? 7 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Transplant dysfunction have been filed in association with TERAZOSIN (terazosin). This represents 1.3% of all adverse event reports for TERAZOSIN.
7
Reports of Transplant dysfunction with TERAZOSIN
1.3%
of all TERAZOSIN reports
0
Deaths
7
Hospitalizations
How Dangerous Is Transplant dysfunction From TERAZOSIN?
Of the 7 reports, 7 (100.0%) required hospitalization.
Is Transplant dysfunction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TERAZOSIN. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does TERAZOSIN Cause?
Therapeutic product effect incomplete (75)
Asthma (66)
Dyspnoea (60)
Drug ineffective (56)
Dizziness (47)
Cough (46)
Chest pain (42)
Malaise (40)
Hospitalisation (37)
Drug hypersensitivity (36)
What Other Drugs Cause Transplant dysfunction?
TACROLIMUS (944)
MYCOPHENOLATE MOFETIL (780)
CYCLOSPORINE (610)
SIROLIMUS (468)
ETANERCEPT (449)
DACLIZUMAB (421)
INFLIXIMAB (405)
PREDNISONE (240)
TACROLIMUS\TACROLIMUS ANHYDROUS (198)
THYMOCYTE IMMUNE GLOBULIN NOS (190)
Which TERAZOSIN Alternatives Have Lower Transplant dysfunction Risk?
TERAZOSIN vs TERAZOSIN\TERAZOSIN
TERAZOSIN vs TERBINAFINE
TERAZOSIN vs TERBINAFINE\TERBINAFINE
TERAZOSIN vs TERBUTALINE
TERAZOSIN vs TERCONAZOLE